Antipsychotic Augmentation vs Monotherapy in Schizophrenia

Slideshow

To augment or not to augment? That is the question.

View the slides in PDF format. Also see: Antipsychotics and Breast Cancer Risk.

Related Videos
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
brain depression
nicotine use
brain schizophrenia
brain
schizophrenia
Related Content
depression

Zuranolone for the Treatment of Adults With Major Depressive Disorder

Joshua Robak, MD;Lior Hilsenrath, MD;Abigail Jaeger, MD;Mark Mullen, MD;Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
July 12th 2024
Article
Here's to a Psychedelic Revolution

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
April 9th 2022
Podcast
polypharmacy

Becoming Comfortable With Discomfort Polypharmacy for Patients With Substance Use Disorders

Nancy Shenoi, MD;Benjamin Li, MD
July 10th 2024
Article
Blue Light Blockers: A Behavior Therapy for Mania

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD;Kellie Newsome, PMH-NP
October 7th 2021
Podcast
innovations

Innovations in Clinical Research

Erin O'Brien
July 8th 2024
Article
weight gain

Which Antidepressant Causes the Least Amount of Weight Gain?

Leah Kuntz
July 4th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.